What departments does CANbridge Pharmaceuticals Inc. have?

CANbridge Pharmaceuticals Inc. has employees across 8 departments including Business Development, Operations, Research, Engineering, Finance.

What is the largest department at CANbridge Pharmaceuticals Inc.?

The largest department at CANbridge Pharmaceuticals Inc. is Research with 3 employees.

Where are CANbridge Pharmaceuticals Inc. employees located globally?

CANbridge Pharmaceuticals Inc. has employees across 3 continents and 5 countries including China, India, United States Of America, Hong Kong, Taiwan.

How has CANbridge Pharmaceuticals Inc.'s team size changed over time?

CANbridge Pharmaceuticals Inc.'s team has decreased from approximately 30 to 27 employees based on available data.

CANbridge Pharmaceuticals Inc. Employee Directory

Q: Who are CANbridge Pharmaceuticals Inc.'s key employees and leadership?

CANbridge Pharmaceuticals Inc.'s key employees include: Chairman, President And Ceo: J. X., Chief Executive Officer: B. W., Chief Commercial Officer (cco): M. C., Vice President - Head Of Global Research: J. W., Vice President Of Business Development And Portfolio Management: D. L..

Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees

CANbridge Pharmaceuticals Inc. is a China-focused biopharmaceutical company accelerating development and commercialization of specialty healthcare products for orphan diseases and targeted cancers, focusing on products that are unavailable or address medical needs that are underserved in the region.

CANbridge has been recognized as a leader in orphan diseases in China. It has a global partnership with WuXi Biologics to develop and commercialize proprietary therapeutics for the treatment of rare genetic diseases. In greater China, it has an exclusive licensing agreement to commercialize Hunterase®, an enzyme replacement therapy for the treatment of Hunter syndrome, developed by GC Pharma and marketed in more than ten countries worldwide. CANbridge also has an oncology portfolio, which includes exclusive rights to develop and commercialize Puma Biotechnology’s NERLYNX® (neratinib), in greater China, as well as rights to other novel candidates.

CANbridge Pharmaceuticals Inc. Global Highlights

Asia
33

China
32
India
1

North America
13

United States Of America
13

CANbridge Pharmaceuticals Inc.'s Leadership

B. W.
Chief Executive Officer
Mobile Phone
Email
M. C.
Chief Commercial Officer (cco)
Mobile Phone
Email
J. W.
Vice President - Head Of Global Research
Mobile Phone
Email
D. L.
Vice President Of Business Development And Portfolio Management
Mobile Phone
Email
K. P.
Head Of Operations And Integrations, Global Research
Mobile Phone
Email
J. X.
Chairman, President And Ceo
Mobile Phone
Email
Y. E. M.
Vp, Business Development And External Innovation
Mobile Phone
Email
P. L.
Senior Vp, Clinical Development & Operations
Mobile Phone
Email

CANbridge Pharmaceuticals Inc. Employee Metrics

100%

50%

0%

2026

2025

Biotechnology
Administrative
Business
Finance
Branding
Other

Contact profiles from CANbridge Pharmaceuticals Inc.

Name

Title

Contact Info

Location

Last Update

X. R.
Reaserch & Develope
Mobile Phone
Email
ChinaBeijing
Apr 15, 2026
H. W.
Ad Of Ra
Mobile Phone
Email
ChinaBeijing
Apr 01, 2026
A. N.
Research Associate
Mobile Phone
Email
United StatesMassachusetts
Apr 16, 2025
M. S.
Business Analyst
Mobile Phone
Email
United StatesMassachusetts
Jul 27, 2023
M. N.
Ra Ad
Mobile Phone
Email
ChinaBeijing
Apr 13, 2026
F. M.
General Manager, Mainland China, Hong Kong & Macau
Mobile Phone
Email
Hong KongCentral and Western
Mar 19, 2025

Frequently Asked Questions

What is CANbridge Pharmaceuticals Inc. known for?

CANbridge Pharmaceuticals Inc. was founded in 2012 operates in the Pharmaceutical Manufacturing industry. The company's main headquarters is located in 4 Burlington Woods Drive Burlington, Massachusetts 01803 United States. Explore CANbridge Pharmaceuticals Inc.'s company overview page for more information.

What is CANbridge Pharmaceuticals Inc.'s most common email format?

CANbridge Pharmaceuticals Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more CANbridge Pharmaceuticals Inc. email formats with LeadIQ.

How many employees does CANbridge Pharmaceuticals Inc. have currently?

CANbridge Pharmaceuticals Inc. has approximately 50 employees as of April 2026. These team members are located across 2 continents, including AsiaNorth America.

Who are CANbridge Pharmaceuticals Inc.'s key employees and leadership?

As of April 2026, CANbridge Pharmaceuticals Inc.'s key employees include:

Chief Executive Officer: B. W.
Chief Commercial Officer (cco): M. C.
Vice President - Head Of Global Research: J. W.
Vice President Of Business Development And Portfolio Management: D. L.
Head Of Operations And Integrations, Global Research: K. P.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

CANbridge Pharmaceuticals Inc. Employee Directory

Find CANbridge Pharmaceuticals Inc. employees' phone numbers or email addresses

Name search is limited — try advanced search instead